These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 680804)

  • 21. Immunologic phenomena in experimental rodentiosis. II. Cellular and humoral factors in immunity to infection with Yersinia pseudotuberculosis.
    Jakoniuk P
    Arch Immunol Ther Exp (Warsz); 1976; 24(1):85-92. PubMed ID: 769740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of clasmatosis of the phagocytes in immunogenesis].
    Grekova NA; Vershilova PA
    Biull Eksp Biol Med; 1976 Aug; 82(8):966-7. PubMed ID: 1026299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them.
    Rasooly G; Olitzki AL; Sulitzeanu D
    Isr J Med Sci; 1966; 2(5):569-84. PubMed ID: 5970644
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunologicc activity of the aged.
    Makinodan T; Perkins EH; Chen MG
    Adv Gerontol Res; 1971; 3():171-98. PubMed ID: 4398644
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aggregated immunoglobulins as antigen-binding receptors of immune lymphocytes].
    Iurin BL; Khorobrykh VV; Kaulen DR; Kul'berg AI
    Biull Eksp Biol Med; 1976 Jun; 81(6):702-4. PubMed ID: 1085180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.
    Ducret JP; Caillé P; Sancho Garnier H; Amiel JL; Michelson M; Hovanessian AG; Youn JK; Lacour F
    J Biol Response Mod; 1985 Apr; 4(2):129-33. PubMed ID: 3998763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].
    Lacour F; Lacour J; Spira A; Michelson M; Petit JY; Delage G; Contesso G; Merlin-Nahon E; Sarrazin D; Viguier J
    Chirurgie; 1980 Nov; 106(9):737-43. PubMed ID: 7009093
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.
    Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E
    Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed hypersensitivity. IV. Hapten-specific delayed reactions; interaction of immune serum and sensitized cells.
    Phair JP; Kantor FS
    J Immunol; 1970 Aug; 105(2):471-5. PubMed ID: 5433701
    [No Abstract]   [Full Text] [Related]  

  • 30. Strain difference in delayed-type hypersensitivity to BCG in mice: role of splenic adherent cells in the primary immune response.
    Nakamura RM; Tanaka H; Tokunaga T
    Immunology; 1982 Dec; 47(4):729-31. PubMed ID: 6216204
    [No Abstract]   [Full Text] [Related]  

  • 31. The immunoglobulin nature of the antigen recognition site on cells mediating transplantation immunity and delayed hypersentivity.
    Mason S; Warner NL
    J Immunol; 1970 Mar; 104(3):762-5. PubMed ID: 4190976
    [No Abstract]   [Full Text] [Related]  

  • 32. [Delayed hypersensitivity in brucellosis infection and vaccination].
    Vershilova PA; Kniazeva ZN
    Vestn Akad Med Nauk SSSR; 1970; 25(8):73-8. PubMed ID: 5492768
    [No Abstract]   [Full Text] [Related]  

  • 33. Polyadenylic-polyuridylic acid as adjuvant in the treatment of operable breast cancer: recent results.
    Lacour J; Lacour F; Ducot B; Spira A; Michelson M; Petit JY; Sarrazin D; Contesso G
    Eur J Surg Oncol; 1988 Aug; 14(4):311-6. PubMed ID: 3044833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective concurrent suppression of the process of rosette-forming cell accumulation during the immune response].
    Simonian SA; Khorobrykh VV; Iurin BL; Golovanova TA; Kul'bert AI
    Biull Eksp Biol Med; 1976 Jun; 81(6):715-7. PubMed ID: 1085182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of an Opisthorchis infestation on antibody formation and delayed hypersensitivity in brucellosis patients].
    Rogozenko GF; Vasil'ev NV; Doroshenko KG; Lepekhin AV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):99-100. PubMed ID: 516962
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental delayed type allergy without demonstrable antibodies. II. In vitro activity of reticulo-endothelial cells.
    Holtzer JD
    Immunology; 1967 Jun; 12(6):713-23. PubMed ID: 6027425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
    [No Abstract]   [Full Text] [Related]  

  • 38. Varied effects of polyadenylic-polyuridylic acid on immune responses.
    Sela M; Mozes E
    Biochimie; 1976; 58(1-2):173-7. PubMed ID: 953051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression in murine brucellosis.
    Zhang J; Gao B; Cun C; Lu X; Wang H; Chen X; Tang L
    Chin Med Sci J; 1993 Sep; 8(3):134-8. PubMed ID: 8142626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of interferon-mediated protein kinase in mouse and human plasma in response to treatment with polyadenylic-polyuridylic acid (poly A:poly U).
    Hovanessian AG; Rivière Y; Montagnier L; Michelson M; Lacour J; Lacour F
    J Interferon Res; 1982; 2(2):209-15. PubMed ID: 6181177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.